Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bayesian-Optimized Dose-Finding of ATTN201 Focused Ultrasound for Behavioral Health

NCT07851038 is registered in ClinicalTrials.gov with Attune Neurosciences Inc as lead sponsor.

NCT NCT07851038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07851038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bayesian-Optimized Dose-Finding of ATTN201 Focused Ultrasound for Behavioral Health
Lead sponsor
Attune Neurosciences Inc
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 5, 2026
Completion date
May 17, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, obsessive compulsive disorder (ocd)